ArticleThe Journal of urology2025
Retroperitoneal Nodal Distribution for Metastatic Seminoma: Is Modified Template Appropriate? A Retrospective Study.
Article in The Journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The role of primary RPLND in clinical stage IIA/B testicular germ cell tumor: a narrative review.Urologie (Heidelberg, Germany) · 2025Review
- Editorial Comment.The Journal of urology · 2025Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSeveral phase 2 trials have investigated the efficacy of retroperitoneal lymph node dissection (RPLND) with a unilateral modified template as the first-line treatment for stage II seminoma. However, the rationale for using modified templates is extrapolated from studies of nonseminomatous germ cell tumor. In this retrospective study, we sought to compare the oncologic outcome of bilateral and unilateral templates and perform a clinical mapping study for metastatic seminoma. MATERIALS AND
methodsPatients who presented with pure seminoma at orchiectomy, retroperitoneal only metastasis either at presentation or relapse, and who underwent primary RPLND from 2016 to 2022 at our institution were reviewed. Pathologic and clinical outcomes were compared after stratification based on dissection templates.
resultsThe cohort included 104 patients with 36 unilateral and 68 bilateral template dissection. The 2-year recurrence-free survival rate was 80.6% for the unilateral group and 86.8% for the bilateral group. Among the recurrences, 66.7% and 90% were outside of the retroperitoneum in unilateral and bilateral groups, respectively. The most common landing zones of metastatic seminoma are para-aortic for left-sided and interaortocaval for right-sided primary tumors. The microscopic metastasis in the contralateral zones ranges from 6% to 11.1%.
conclusionsThe most common landing zones of seminoma mirror nonseminomatous germ cell tumor. Primary RPLND provides excellent oncologic outcomes for early stage II seminoma. In the early experience in stage II seminoma, we have favored bilateral template dissections. More data are needed to better understand whether bilateral templates should be uniformly performed in pure seminoma.
Indexed as
Identifiers
39977396What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.